Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

PharmSci 360 2026 heads to New Orleans this October

By Brian Buntz | July 7, 2026

The American Association of Pharmaceutical Scientists (AAPS) will hold its 2026 PharmSci 360 meeting October 25 to 28 at the Ernest N. Morial Convention Center in New Orleans. The event is the association’s flagship annual gathering, drawing thousands of scientists from across academia, industry, and government.

AAPS, which counts roughly 7,000 members, positions PharmSci 360 as a meeting that pairs the scale of a large scientific conference with the focus of a smaller specialist forum. Its programming is built on five tracks that follow the drug development process, so attendees can concentrate on a single track or move across any of them depending on the problems they are trying to solve.

The program runs across tracks that follow the development pipeline, including Preclinical, Clinical, and Translational Sciences; Formulation and Delivery; Manufacturing and Analytical Characterization; and Bioanalytics, plus an Innovator Curated Track built around research integrity and open science. The keynote lineup gives each track a concrete anchor. In Formulation and Delivery, Purdue’s Lynne Taylor makes the case for amorphous solid dispersions in the oral delivery of next-generation drugs, and the University of Macau’s Defang Ouyang traces the past, present, and future of AI for drug delivery. On the characterization side, the University of Connecticut’s Diane Burgess (a past AAPS president) headlines with a talk on understanding complex parenteral products, and digiM’s Shawn Zhang presents microstructure-based predictive drug development on the closing day.

AI and modeling are a recurring theme. Sessions pair machine learning with mechanistic modeling in formulation, apply AI to predictive manufacturing and product intelligence, and bring automation into the bioanalytical lab through a symposium on clinical sampling and BA lab AI. Translational science gets a timely hook in Eli Lilly’s Maria Posada leading a hot-topic session on GLP-1 agonists and the gastric-emptying interactions that can reshape drug absorption. Bookending the meeting are an opening plenary from Julie Gerberding of the Foundation for the NIH and a closing plenary from David Berry.

Event at a glance

  • What: AAPS 2026 PharmSci 360
  • When: October 25 to 28, 2026
  • Where: Ernest N. Morial Convention Center, New Orleans
  • Host: American Association of Pharmaceutical Scientists


Filed Under: PharmSci360
Tagged With: AAPS, AAPS PharmSci 360 2026, AI drug delivery, amorphous solid dispersions, bioanalysis, complex parenterals, drug development, formulation and delivery, gastric emptying DDI, GLP-1 agonists, machine learning formulation, manufacturing characterization, microstructure intelligence, New Orleans 2026, open science, pharmaceutical conference, pharmaceutical sciences, PharmSci 360, preclinical sciences, research integrity, translational research
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at [email protected].

“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE